Rabbit Haemorrhagic Disease (RHD) prevention program based on the use of a European RHDV-2 vaccine

Home Knowledge Rabbit Haemorrhagic Disease (RHD) prevention program based on the use of a European RHDV-2 vaccine

Rabbit Haemorrhagic Disease (RHD) prevention program based on the use of a European RHDV-2 vaccine


These two studies were aimed to evaluate the efficacy of ERAVAC® in naïve rabbits up to 6 months after immunization, although protection for a longer period of time (up to 12 month) as an aid to establish the most adequate prevention program for the disease was also explored.

About this article

Appeared in

SVEPM Conference, 2018

Date

May 18, 2018

Authors

Sánchez-Matamoros, A.; Boix, O.; Ruiz, M. C.; Woodward, M.; Maldonado, J.

Summary

This study demonstrates the following: • RHDV-2 vaccine stimulates the humoral response at 7 dpv, inducing high and long lasting antibody titers up to 12 mpv. • RHDV-2 vaccine confers protective immunity to virulent heterologous challenge. • A RHDV-2 prevention program could be based on a vaccination interval of at least 12 months.

Related services

Related products

Share this on